Insulet Corp (PODD)
235.61
+4.08
(+1.76%)
USD |
NASDAQ |
Nov 01, 16:00
235.71
+0.10
(+0.04%)
After-Hours: 20:00
Insulet Enterprise Value: 17.10B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 17.10B |
| October 31, 2024 | 16.81B |
| October 30, 2024 | 16.74B |
| October 29, 2024 | 16.87B |
| October 28, 2024 | 16.94B |
| October 25, 2024 | 16.96B |
| October 24, 2024 | 17.24B |
| October 23, 2024 | 17.04B |
| October 22, 2024 | 17.17B |
| October 21, 2024 | 17.16B |
| October 18, 2024 | 17.17B |
| October 17, 2024 | 16.64B |
| October 16, 2024 | 16.75B |
| October 15, 2024 | 16.71B |
| October 14, 2024 | 16.88B |
| October 11, 2024 | 16.92B |
| October 10, 2024 | 16.79B |
| October 09, 2024 | 16.83B |
| October 08, 2024 | 16.66B |
| October 07, 2024 | 16.55B |
| October 04, 2024 | 16.70B |
| October 03, 2024 | 16.70B |
| October 02, 2024 | 16.89B |
| October 01, 2024 | 17.02B |
| September 30, 2024 | 16.90B |
| Date | Value |
|---|---|
| September 27, 2024 | 16.85B |
| September 26, 2024 | 17.08B |
| September 25, 2024 | 17.32B |
| September 24, 2024 | 17.34B |
| September 23, 2024 | 17.33B |
| September 20, 2024 | 17.16B |
| September 19, 2024 | 17.24B |
| September 18, 2024 | 17.13B |
| September 17, 2024 | 17.09B |
| September 16, 2024 | 16.98B |
| September 13, 2024 | 16.97B |
| September 12, 2024 | 16.73B |
| September 11, 2024 | 16.54B |
| September 10, 2024 | 16.46B |
| September 09, 2024 | 15.94B |
| September 06, 2024 | 15.63B |
| September 05, 2024 | 15.73B |
| September 04, 2024 | 15.48B |
| September 03, 2024 | 15.07B |
| August 30, 2024 | 14.79B |
| August 29, 2024 | 14.96B |
| August 28, 2024 | 14.91B |
| August 27, 2024 | 14.08B |
| August 26, 2024 | 13.25B |
| August 23, 2024 | 13.55B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.685B
Minimum
Mar 18 2020
23.79B
Maximum
May 12 2023
16.56B
Average
16.72B
Median
Jan 04 2021
Enterprise Value Benchmarks
| Baxter International Inc | 29.17B |
| Boston Scientific Corp | 131.03B |
| Abbott Laboratories | 213.13B |
| Globus Medical Inc | 10.08B |
| Bioventus Inc | 1.273B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 188.60M |
| Revenue (Quarterly) | 488.50M |
| Total Expenses (Quarterly) | 433.90M |
| EPS Diluted (Quarterly) | 2.59 |
| Gross Profit Margin (Quarterly) | 67.74% |
| Profit Margin (Quarterly) | 38.61% |
| Earnings Yield | 2.33% |
| Operating Earnings Yield | 1.52% |
| Normalized Earnings Yield | 2.334 |